UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 71

Sortiert nach

Die Anwendung von Real-world-Evidenz in Entscheidungsprozessen der Arzneimittelregulation

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2024-02, Vol.67 (2), p.149-154

2024

Volltextzugriff (PDF)

Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters

Pharmacology & therapeutics (Oxford), 2011-03, Vol.129 (3), p.352-368

2011

Volltextzugriff (PDF)

Agmatine (decarboxylated L-arginine): physiological role and therapeutic potential

Pharmacology & therapeutics (Oxford), 2012-03, Vol.133 (3), p.351-365

2012

Volltextzugriff (PDF)

Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer's disease mice

PloS one, 2024-02, Vol.19 (2), p.e0296959-e0296959

2024

Volltextzugriff (PDF)

Familial occurrence of systemic mast cell activation disease

PloS one, 2013-09, Vol.8 (9), p.e76241-e76241

2013

Volltextzugriff (PDF)

A Novel Rat Infant Model of Medial Temporal Lobe Epilepsy Reveals New Insight into the Molecular Biology and Epileptogenesis in the Developing Brain

Neural plasticity, 2024-07, Vol.2024 (1), p.9946769

2024

Volltextzugriff (PDF)

Structure–activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP)

Bioorganic & medicinal chemistry, 2011-03, Vol.19 (6), p.2090-2102

2011

Volltextzugriff (PDF)

Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression

Journal of neurochemistry, 2009-10, Vol.111 (2), p.403-416

2009

Volltextzugriff (PDF)

Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes

The pharmacogenomics journal, 2022-03, Vol.22 (2), p.136-144

2022

Volltextzugriff (PDF)

Perspective of elderly patients on chronic use of potentially inappropriate medication - Results of the qualitative CIM-TRIAD study

PloS one, 2018-09, Vol.13 (9), p.e0202068-e0202068

2018

Volltextzugriff (PDF)

The Janus-like Association between Proton Pump Inhibitors and Dementia

Current Alzheimer research, 2021-01, Vol.18 (6), p.453

2021

Volltextzugriff (PDF)

Hyperuricemia and dementia - a case-control study

BMC neurology, 2018-08, Vol.18 (1), p.131-131, Article 131

2018

Volltextzugriff (PDF)

Cav3 T-Type Voltage-Gated Ca2+ Channels and the Amyloidogenic Environment: Pathophysiology and Implications on Pharmacotherapy and Pharmacovigilance

International journal of molecular sciences, 2022-03, Vol.23 (7), p.3457

2022

Volltextzugriff (PDF)

Motor Cortex Theta and Gamma Architecture in Young Adult APPswePS1dE9 Alzheimer Mice

PloS one, 2017-01, Vol.12 (1), p.e0169654-e0169654

2017

Volltextzugriff (PDF)

The application of real-world evidence in drug regulatory decision-making

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2024-02, Vol.67 (2), p.149-154

2024

Volltextzugriff (PDF)

Whole genome transcriptome data from the WT cortex and hippocampus of female and male control and APP/PS1 Alzheimer's disease mice

Data in brief, 2023-10, Vol.50, p.109594-109594, Article 109594

2023

Volltextzugriff (PDF)

Integrated pathway-based approach identifies association between genomic regions at CTCF and CACNB2 and schizophrenia

PLoS genetics, 2014-06, Vol.10 (6), p.e1004345-e1004345

2014

Volltextzugriff (PDF)

Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases

Internal Medicine, 2011, Vol.50(6), pp.611-615

2011

Volltextzugriff (PDF)

Informal caregivers' perspectives on health of and (potentially inappropriate) medication for (relatively) independent oldest-old people - a qualitative interview study

BMC geriatrics, 2018-07, Vol.18 (1), p.169-10, Article 169

2018

Volltextzugriff (PDF)

A systematic eQTL study of cis-trans epistasis in 210 HapMap individuals

European journal of human genetics : EJHG, 2012-01, Vol.20 (1), p.97-101

2012

Volltextzugriff (PDF)

Oral antidiabetic drugs and dementia risk: Does treatment matter?

Neurology, 2017-10, Vol.89 (18), p.1848

2017

Volltextzugriff (PDF)

Gender-Specific Hippocampal Dysrhythmia and Aberrant Hippocampal and Cortical Excitability in the APPswePS1dE9 Model of Alzheimer’s Disease

Neural plasticity, 2016-01, Vol.2016, p.7167358-16

2016

Volltextzugriff (PDF)

Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis

JAMA neurology, 2016-04, Vol.73 (4), p.410

2016

Volltextzugriff (PDF)

Enrichment designs using placebo nonresponders

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2020-05, Vol.19 (3), p.303-314

2020

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(70)
Dissertationen
(1)

Sprache

Englisch
(65)
Japanisch
(10)
Deutsch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Die Anwendung von Real-world-Evidenz in Entscheidungsprozessen der Arzneimittelregulation

Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters

Agmatine (decarboxylated L-arginine): physiological role and therapeutic potential

Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer's disease mice

Familial occurrence of systemic mast cell activation disease

A Novel Rat Infant Model of Medial Temporal Lobe Epilepsy Reveals New Insight into the Molecular Biology and Epileptogenesis in the Developing Brain

Structure–activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP)

Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression

Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes

Perspective of elderly patients on chronic use of potentially inappropriate medication - Results of the qualitative CIM-TRIAD study

The Janus-like Association between Proton Pump Inhibitors and Dementia

Hyperuricemia and dementia - a case-control study

Cav3 T-Type Voltage-Gated Ca2+ Channels and the Amyloidogenic Environment: Pathophysiology and Implications on Pharmacotherapy and Pharmacovigilance

Genome-Wide Association-, Replication-, and Neuroimaging Study Implicates HOMER1 in the Etiology of Major Depression

Motor Cortex Theta and Gamma Architecture in Young Adult APPswePS1dE9 Alzheimer Mice

The application of real-world evidence in drug regulatory decision-making

Whole genome transcriptome data from the WT cortex and hippocampus of female and male control and APP/PS1 Alzheimer's disease mice

Integrated pathway-based approach identifies association between genomic regions at CTCF and CACNB2 and schizophrenia

Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases

Informal caregivers' perspectives on health of and (potentially inappropriate) medication for (relatively) independent oldest-old people - a qualitative interview study

A systematic eQTL study of cis-trans epistasis in 210 HapMap individuals

Oral antidiabetic drugs and dementia risk: Does treatment matter?

Gender-Specific Hippocampal Dysrhythmia and Aberrant Hippocampal and Cortical Excitability in the APPswePS1dE9 Model of Alzheimer’s Disease

Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis

Enrichment designs using placebo nonresponders

Suchergebnisse filtern